Compare ANL & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANL | PHUN |
|---|---|---|
| Founded | 2004 | 2009 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | EDP Services |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.0M | 55.9M |
| IPO Year | 2023 | N/A |
| Metric | ANL | PHUN |
|---|---|---|
| Price | $1.05 | $2.10 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $7.25 |
| AVG Volume (30 Days) | 12.5K | ★ 165.6K |
| Earning Date | 11-07-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,357,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $73.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $1.83 |
| 52 Week High | $2.99 | $6.29 |
| Indicator | ANL | PHUN |
|---|---|---|
| Relative Strength Index (RSI) | 23.81 | 41.56 |
| Support Level | $1.32 | $1.83 |
| Resistance Level | $1.59 | $2.13 |
| Average True Range (ATR) | 0.15 | 0.12 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 1.69 | 61.54 |
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.